28.01.2016
- Three major drugs companies have joined forces with three leading UK universities to translate ground-breaking academic science into new medicines for a broad range of diseases...
26.01.2016
- More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...
13.01.2016
- Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...
05.01.2016
- Swedish drugmaker AstraZeneca has gained approval from the US Food and Drug Administration (FDA) to market Zurampic, a treatment for gout, the debilitating form of inflammatory...
18.12.2015
- The third week of December was a busy one for AstraZeneca. Just days after the British-Swedish drugmaker confirmed talks with privately owned biotech Acerta Pharma about an...
15.12.2015
- AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...
11.12.2015
- Catalent Pharma Solutions has signed an exclusive long term supply agreement with Pfizer to produce over-the-counter heartburn treatment, Nexium 24HR (esomeprazole), branded as...
30.11.2015
- Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...
